New study provides insight into blood signatures of inflammation

May 8, 2018, Boston University School of Medicine

A new study from Boston University Schools of Medicine (BUSM) and Public Health (BUSPH) identifies a pattern of inflammation associated with cardio-metabolic risks among participants in the Black Women's Health Study, as well as two independent groups of vulnerable women. These findings could help underserved patients benefit from precision medicine and personalized profiles of disease risk.

According to the researchers, alone is an imperfect measure of obesity-associated disease risks, such as for Type 2 diabetes, because there are some individuals with chronic obesity who are apparently protected from cardio-metabolic complications and lean individuals with high cardiovascular and diabetes risks. Abnormal, unresolved inflammation in blood and adipose (fat) tissue, rather than obesity per se, is thought to be important for development of disease. Certain biomarkers show promise in predicting obesity-associated diabetes risk; however, the clinical utility of single biomarkers is limited for complex disease phenotypes such as these.

The research team took a data-driven, systems biology approach to discover six cytokine signatures associated with Type 2 diabetes risk in a vulnerable population: African American women with obesity and varying degrees of metabolic health. These six distinct signatures are patterns of sixteen cytokines/chemokines that promote or reduce inflammation.

Analyses of plasma samples from participants in the Black Women's Health Study, formed the basis for the discovery dataset, which was then validated in two separate groups, African American women volunteers with obesity who had donated plasma to the Komen Tissue Bank, and African American women with obesity who were breast reduction surgical patients at a safety net hospital in Greater Boston. The patterns or signatures in the validation cohorts closely resembled the distributions in the discovery cohort.

"These findings are highly relevant to an understudied and underserved population that experiences elevated risks for co-morbidities of . The overall impact of this report is high because of the potential utility of the new signatures just discovered and validated, which could assist clinical decision making with more personalized information," explained corresponding author Gerald V. Denis, PhD, associate professor of pharmacology and medicine at BUSM.

These findings appear in the journal PLOS ONE.

Explore further: Type 2 diabetes associated with risk of aggressive breast cancer in black women

Related Stories

Type 2 diabetes associated with risk of aggressive breast cancer in black women

November 15, 2017
African American women with type 2 diabetes (often referred to as adult-onset diabetes) are at a greater risk for developing breast cancer.

Study shows answers for treating obesity-related diseases may reside in fat tissue

July 4, 2011
Researchers at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have shown that the quality – not just the quantity – of adipose, or fat, tissue is a significant contributing factor in ...

African-American women with type 2 diabetes may have higher risk for ER-neg breast cancer

November 15, 2017
Among African-American women, those with type 2 diabetes may have a higher risk of developing estrogen receptor (ER)-negative breast cancer.

Obesity may influence rheumatoid arthritis blood tests

April 10, 2017
New research reveals that in women, obesity may influence blood tests used to diagnose and monitor rheumatoid arthritis. The findings, which appear in Arthritis Care & Research, indicate that physicians need to take obesity ...

Common virus tied to diabetes, heart disease in women under 50

February 23, 2017
A type of herpes virus that infects about half of the U.S. population has been associated with risk factors for type 2 diabetes and heart disease in normal-weight women aged 20 to 49, according to a new UC San Francisco-led ...

Key molecular players in obesity-associated type 2 diabetes identified

November 19, 2015
There is strong evidence that inflammation promotes obesity-associated type 2 diabetes and diabetes complications. However, clinical trials with anti-inflammatory drugs have only been modestly effective for treating Type ...

Recommended for you

Fatty acids can slow down an overheated immune system

September 21, 2018
Sometimes, the immune system mistakenly attacks the body's healthy tissue by responding to infections that do not exist. This causes chronic inflammation and leads to diseases including lupus (SLE), and this is what happens ...

Study reveals a promising alternative to corticosteroids in acute renal failure treatment

September 21, 2018
A protein produced by the human body appears to be a promising new drug candidate to treat conditions that lead to acute renal failure. This is shown by a study conducted at São Paulo State University (UNESP) in São José ...

Rethinking an inflammatory receptor's obesity connection

September 12, 2018
Toll-like receptor 4 (TLR4) is a protein that plays a vital role in the body's immune response by sensing the presence of infection. It has long been thought to also sense particular types of fats, which suggested a mechanism ...

Excessive airway nerves tied to more severe asthma symptoms, study finds

September 5, 2018
A new study implicates remodeling of nerves in the airways as a key contributor to heightened sensitivity and airway constriction in patients with asthma.

Genetics and pollution drive severity of asthma symptoms

August 31, 2018
Asthma patients, with a specific genetic profile, exhibit more intense symptoms following exposure to traffic pollution, according to researchers at the National Institutes of Health and collaborators. The study appeared ...

Clarifying the role of a protein released by immune 'dendritic' cells could yield better treatments

August 30, 2018
Inflammatory bowel disease (IBD), which afflicts millions of people worldwide, arises when the immune system mounts an overly aggressive response against microorganisms, dietary substances, or cells of the gut. A*STAR researchers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.